Premium
Pharmacogenetic testing: Is a lab test able to replace clinical acumen and thoughtful medication management?
Author(s) -
Algon Sibel
Publication year - 2018
Publication title -
the brown university child and adolescent behavior letter
Language(s) - English
Resource type - Journals
eISSN - 1556-7575
pISSN - 1058-1073
DOI - 10.1002/cbl.30340
Subject(s) - pharmacogenetics , food and drug administration , headline , genetic testing , test (biology) , clinical trial , medicine , medical physics , intensive care medicine , psychology , pharmacology , biology , business , genotype , genetics , advertising , paleontology , gene
In short, most often the answer to the question posed in this article's headline is “Not yet.” Pharmacogenetics is a field of research looking for predictable correlations between genetic variations (polymorphisms) and clinical responses to medications. At present, there are over 20 such tests available at high cost. None are regulated by the Food and Drug Administration (FDA), and most lack double‐blind randomly controlled trials.